Figure 1 - uploaded by Gene L. Bowman
Content may be subject to copyright.
Presents mean vitamin D concentration for the 122 non-fallers, 29 single fallers, and 8 multi-fallers. There was a significant difference across groups (ANOVA, p=0.0387). Post-hoc pairwise analysis between each group showed a significant difference in vitamin concentration between non-fallers vs. multiple fallers (p=0.04). Analysis in non-fallers vs. single fallers and single fallers vs. multiple fallers did not reach statistical significant (p=0.08 and p=0.33 respectively) 

Presents mean vitamin D concentration for the 122 non-fallers, 29 single fallers, and 8 multi-fallers. There was a significant difference across groups (ANOVA, p=0.0387). Post-hoc pairwise analysis between each group showed a significant difference in vitamin concentration between non-fallers vs. multiple fallers (p=0.04). Analysis in non-fallers vs. single fallers and single fallers vs. multiple fallers did not reach statistical significant (p=0.08 and p=0.33 respectively) 

Source publication
Article
Full-text available
Objectives: To elucidate the mechanism through which vitamin D is associated with decreased falls. Design: This was a convenience sample from a larger observational study examining correlations between vitamin D and 1) falls, 2) motor function, and 3) cognition (n=159). Setting: Falls data were collected via weekly on-line surveys completed in...

Similar publications

Article
Full-text available
Human development is a bidirectional, person-context relational process, but scarce evidence is available about the relation between the individual variability across the life-span and the neighborhood ecological assets. Therefore, it is important that research focus not only on personal characteristics but on ecological assets as well. This way th...

Citations

... These activities are linked to sophisticated motor control and are necessary for the mental control of actions and the mental carrying out of plans as they are implemented [95]. When it comes to cognitive issues, older persons who are capable of taking care of themselves have lower blood levels of 25hydroxyvitamin D [96]. Moreover, there is a link between certain human VDR gene variants and an increased risk of cognitive deterioration. ...
Article
This study explores the complex link between vitamin D and neurological illnesses, focusing on how vitamin D affects possible risk factors, therapeutic applications, and the trajectory of the disease. An epidemiological study has linked vitamin D insufficiency to several neurological conditions, including Parkinson's disease, Alzheimer's disease, and multiple sclerosis. It is hypothesized that immunomodulatory and anti-inflammatory properties of vitamin D contribute to its neu-roprotective effects. Two major mechanisms in dementia include neuroinflammation and oxidative stress. Adequate levels of vitamin D have been shown in both animal models and human studies to enhance both clinical outcomes and the duration of illness in those who have it. Other ways that vitamin D contributes to its therapeutic potential include the production of neurotrophic factors, control over neurotransmitter synthesis, and preservation of the blood-brain barrier. Despite the encouraging outcomes, research is still being conducted to determine the optimal dosage and long-term benefits of vitamin D supplementation on brain function. In order to furnish precise directives and clarify the processes behind the neuroprotective impacts of vitamin D, future research must focus on large-scale randomized controlled studies.. This study highlights the significance of maintaining adequate levels of vitamin D as a modifiable risk factor for neurological disorders. Further study is also required to comprehend the possible medical benefits of this vitamin fully.
... While it is mostly derived from exposure to the sun, vitamin D deficiency remains prevalent among some populations [3][4][5][6] and is associated with multiple diseases ranging from breast cancer to insulin-dependent diabetes [7,8]. Vitamin D deficiency has also been implicated to play a role in brain-related diseases and disorders such as Parkinson's disease (PD) [9][10][11][12], schizophrenia (SCZ) [13][14][15], depression [16][17][18], Alzheimer's disease (AD) [19][20][21], and multiple sclerosis (MS) [22][23][24]. More recent evidence suggests that brain and cerebrospinal fluid 25(OH)D is associated with lower odds of dementia and mild cognitive impairment [25,26]. ...
Article
Full-text available
Vitamin D deficiency is a global problem. Vitamin D, the vitamin D receptor, and its enzymes are found throughout neuronal, ependymal, and glial cells in the brain and are implicated in certain processes and mechanisms in the brain. To investigate the processes affected by vitamin D deficiency in adults, we studied vitamin D deficient, control, and supplemented diets over 6 weeks in male and female C57Bl/6 mice. The effect of the vitamin D diets on proliferation in the neurogenic niches, changes in glial cells, as well as on memory, locomotion, and anxiety-like behavior, was investigated. Six weeks on a deficient diet was adequate time to reach deficiency. However, vitamin D deficiency and supplementation did not affect proliferation, neurogenesis, or astrocyte changes, and this was reflected on behavioral measures. Supplementation only affected microglia in the dentate gyrus of female mice. Indicating that vitamin D deficiency and supplementation do not affect these processes over a 6-week period.
... Cross-sectional studies consistently demonstrate a correlation between lower serum vitamin D levels and increased motor disability in Parkinson's disease: lower vitamin D levels are associated with worse motor function [120,121].Yet, it remains unclear whether vitamin D directly modifies disease severity or if these associations stem from "inverse causality," where patients with more severe symptoms tend to be less mobile, receiving reduced sun exposure. In the realm of cognitive function, numerous studies highlight an association between low vitamin D levels and poorer cognition in the general population [122,123]. ...
... With regard to cognitive function in the general population, whereas numerous studies have shown an association between low vitamin D levels and worse cognition [164,165], intervention studies have failed to show benefits from vitamin D supplementation [165]. ...
Article
Vitamin D insufficiency or deficiency (VDD) is a very prevalent condition in the general population. Vitamin D is necessary for optimal bone mineralization, but apart from the bone effects, preclinical and observational studies have suggested that vitamin D may have pleiotropic actions, whereas VDD has been linked to several diseases and higher all-cause mortality. Thus, supplementing vitamin D has been considered a safe and inexpensive approach to generate better health outcomes-and especially so in frail populations. Whereas it is generally accepted that prescribing of vitamin D in VDD subjects has demonstrable health benefits, most randomized clinical trials, although with design constraints, assessing the effects of vitamin D supplementation on a variety of diseases have failed to demonstrate any positive effects of vitamin D supplementation. In this narrative review, we first describe mechanisms through which vitamin D may exert an important role in the pathophysiology of the discussed disorder, and then provide studies that have addressed the impact of VDD and of vitamin D supplementation on each disorder, focusing especially on randomized clinical trials and meta-analyses. Despite there already being vast literature on the pleiotropic actions of vitamin D, future research approaches that consider and circumvent the inherent difficulties in studying the effects of vitamin D supplementation on health outcomes are needed to assess the potential beneficial effects of vitamin D. The evaluation of the whole vitamin D endocrine system, rather than only of 25-hydroxyvitamin D levels before and after treatment, use of adequate and physiologic vitamin D dosing, grouping based on the achieved vitamin D levels rather than the amount of vitamin D supplementation subjects may receive, and sufficiently long follow-up are some of the aspects that need to be carefully considered in future studies.
... The positive and linear pattern identified for vitamin D status and global cognition in women has many precedents in the literature. Improved performance throughout the range was reported in mixed-sex studies using the MMSE [6,47], as well as other measures of global cognition such as the abbreviated mental test [5] and composite scores [3,4,48]. While nonlinear patterns have also been previously reported in relation to global cognition [14,15], they do not resemble the complex pattern identified in our study for men. ...
Article
Full-text available
Low vitamin D status has been linked to adverse cognitive outcomes in older adults. However, relationships at higher levels remain uncertain. We aimed to clarify patterns of association between vitamin D status and cognitive performance, using flexible regression methods, in 4872 middle- to older-aged adults (2678 females) from the Busselton Healthy Ageing Study. Cross-sectional associations of serum levels of 25-hydroxyvitamin D (25OHD) and performance in cognitive domains were modelled using linear regression and restricted cubic splines, controlling for demographic, lifestyle, and health factors. Mean ± SD serum 25OHD levels were 78 ± 24 nM/L for women and 85 ± 25 nM/L for men. Increasing levels in women were associated with better global cognition (linear trend, p = 0.023) and attention accuracy (continuity of attention), with improvement in the latter plateauing around levels of 80 nM/L (nonlinear trend, p = 0.035). In men, increasing levels of serum 25OHD were associated with better attention accuracy (linear trend, p = 0.022), but poorer semantic verbal fluency (linear trend, p = 0.025) and global cognition (nonlinear trend, p = 0.015). We identified patterns of association between serum 25OHD levels and cognitive performance that may reflect early dose–response relationships, particularly in women. Longitudinal analyses extending through to older ages may help to clarify the nature, strength, and temporality of these relationships.
... La función cognitiva se ve afectada por la edad y el uso de la terapia hormonal 21,22 . La deficiencia de 25(OH)D disminuye el rendimiento en las pruebas de función cognitiva [23][24][25][26][27][28] , sin embargo, en un estudio mexicano no se encontró relación entre la 25(OH)D y el rendimiento cognitivo 29 y en otro no se encontró relación con la demencia en hombres 30 . ...
Article
Full-text available
Introducción: Las concentraciones bajas de vitamina D se han asociado con la pérdida de masa muscular y la alteración de la función cognitiva. Objetivo: Conocer la relación de la concentración sanguínea de vitamina D con la masa muscular y la función cognitiva en mujeres posmenopáusicas. Materiales y métodos: Se estudiaron 99 mujeres posmenopáusicas ≥ 50 años. Se midió la circunferencia de la pantorrilla, los pliegues cutáneos tricipital, bicipital, subescapular y suprailíaco. Se calcularon: el área muscular del brazo, el área muscular libre de hueso y la masa muscular total. Se realizó la prueba corta de desempeño físico (PCDF), se aplicó el cuestionario de diagnóstico rápido de sarcopenia (SARC-F) y el Mini Examen del Estado Mental (MMSE). Se tomó una muestra de sangre para medir la concentración de vitamina D en sangre. Para el análisis estadístico se utilizó la prueba U de Mann-Whitney y análisis de correlación de Spearman. Resultados: Se encontró que a mayor edad hubieron mayores concentraciones de vitamina D y mayor puntaje SARC-F. Las concentraciones de vitamina D se correlacionaron negativamente con la fuerza de agarre, la PCDF y la puntuación total del MMSE. Conclusiones: La vitamina D no tuvo una influencia positiva sobre la masa muscular. Se observó un mejor desempeño en el MMSE en aquellas con concentraciones más bajas de vitamina D.
... While many studies have demonstrated an association between vitamin D level and cognition in the general population, the few clinical trials that have been done fail to show improvement with supplementation (110)(111)(112)(113)(114)(115)(116)(117)(118)(119). Even less is known about the effects of vitamin D on cognition in Parkinson's disease, and study findings have been inconsistent ( Table 1). ...
Article
Full-text available
Vitamin D is a fat-soluble secosteroid that exerts its effects by binding to the vitamin D receptor (VDR), through which it directly and indirectly modulates the expression of hundreds to thousands of genes. While originally known for its role in regulating calcium homeostasis and metabolism, vitamin D is now associated with many other health conditions, including Parkinson's disease (PD). A high prevalence of vitamin D deficiency has been noted in PD for at least the past two decades. These findings, along with the discovery that the VDR and 1α-hydroxylase, the enzyme that converts vitamin D to its active form, are highly expressed in the substantia nigra, led to the hypothesis that inadequate levels of circulating vitamin D may lead to dysfunction or cell death within the substantia nigra. Studies investigating the relationship between vitamin D status and PD, however, have been inconsistent. Two prospective studies examined the association between mid-life vitamin D levels and risk of PD and produced conflicting results—one demonstrated an increased risk for PD with lower mid-life vitamin D levels, and the other showed no association between vitamin D and PD risk. One of the most consistent findings in the literature is the inverse association between serum vitamin D level and motor symptom severity in cross-sectional studies. While these data suggest that vitamin D may modify the disease, another likely explanation is confounding due to limited mobility. Fall risk has been associated with vitamin D in PD, but more study is needed to determine if supplementation decreases falls, which has been demonstrated in the general population. The association between vitamin D and non-motor symptoms is less clear. There is some evidence that vitamin D is associated with verbal fluency and verbal memory in PD. Studies in PD have also shown associations between vitamin D status and mood, orthostatic hypotension and olfactory impairment in PD. While more research is needed, given the numerous potential benefits and limited risks, vitamin D level assessment in PD patients and supplementation for those with deficiency and insufficiency seems justified.
... Vitamin D deficiency is common in older adults [3] and has been associated with falls [4,5], muscle loss [6] and frailty [7,8]. Early trials of vitamin D supplementation in preventing falls demonstrated a reduction in risk compared to non-supplemented controls [9][10][11]. ...
Article
Full-text available
Recent guidelines have advocated against the use of vitamin D supplementation as a means to prevent falls in older adults. However, meta-analyses of the available trials have reached divergent conclusions, and the key design features of these trials have not been well characterized. We conducted a systematic review of 30 randomized trials that reported the effects of vitamin D supplements on falls. Trials were identified by reviewing references of published meta-analyses and updated with a systematic PubMed search. We assessed three key design features: (1) recruitment of participants with vitamin D deficiency or insufficiency; (2) provision of daily oral vitamin D supplementation; and (3) utilization of highly sensitive at-event falls ascertainment. The trials enrolled a median of 337 (IQR: 170-1864) participants. Four (13.3%) trials restricted enrollment to those who were at least vitamin D insufficient, 18 (60.0%) included at least one arm providing daily supplementation, and 16 (53.3%) used at-event reporting. There was substantial heterogeneity between trials, and no single trial incorporated all three key design features. Rather than concluding that vitamin D is ineffective as a means to prevent falls, these findings suggest that existing trial evidence is insufficient to guide recommendations on the use of vitamin D supplements to prevent falls.
... Although the elderly are able to photosynthesize vitamin D, their capacity to do so is mark- edly diminished when compared with that of young indi- viduals [45], therefore the only way to reach the recom- mended levels is through supplementation. Recent literature provides growing evidence of a positive correlation between vitamin D plasma levels and neuropsychological tests scores [16,[46][47][48]. Preclinical studies have suggested a number of mechanisms of how vitamin D could play a protective and regulatory role in the brain [49], some of them relating to the reduction of nitrosative stress demonstrated in animal brains [50] and Aβ-clearance across the BBB [22]. ...
Article
Full-text available
Background: Mild cognitive impairment (MCI) has an increased rate of progression to dementia. Alterations of some metabolic factors, such as deficiency of vitamin D, are a risk factor for cognitive deterioration. Vitamin D is involved in the clearance of β-amyloid (Aβ) from the brain. We have reported that lymphocytes from Alzheimer's disease (AD) patients have an increased susceptibility to oxidative death by H2O2 exposure, but currently it is unknown if this characteristic is modifiable in vivo. Objective: To determine if correction of low vitamin D levels protects lymphocytes from oxidative death and increases Aβ1-40 plasma levels in MCI and very early AD (VEAD) patients. Method: Sixteen MCI, 11 VEAD and 25 healthy control (HC) voluntaries were evaluated with the Clinical Dementia Rating (CDR), Montreal Cognitive assessment (MoCA), and Memory Index score (MIS). Lymphocyte death was measured by flow cytometry after 20h exposure to H2O2. In patients with low levels of vitamin D -11 MCI, 9 VEAD and 20 HC- lymphocyte H2O2-death, plasma Aβ1-40 levels and cognitive status were evaluated pre- and post-vitamin D supplementation for 6 months. Results: Lymphocytes from MCI and VEAD patients showed increased susceptibility to oxidative death at study entry. In MCI, but not VEAD patients, lymphocyte susceptibility to death and Aβ1-40 levels plasma levels improved after 6 months of vitamin D supplementation. In addition, cognitive status on follow-up (18 months) improved in MCI patients after vitamin D supplementation. Conclusion: Vitamin D supplementation may be beneficial in MCI. The lack of effect in VEAD may be due to a more advanced stage or different characteristics of the neurodegenerative process.
... These functions are required for the cognitive control of behavior and the execution of cognitive programs in real time, and are involved in high-level motor control [208]. In older adults living independently, low serum 25(OH)D concentrations were shown to be significantly associated with cognitive impairment [209]. In addition, certain variants of human VDR gene are associate with increased risk of cognitive decline [176,179]. ...
Article
Full-text available
Vitamin D system comprises hormone precursors, active metabolites, carriers, enzymes, and receptors involved in genomic and non-genomic effects. In addition to classical bone-related effects, this system has also been shown to activate multiple molecular mediators and elicit many physiological functions. In vitro and in vivo studies have, in fact, increasingly focused on the “non-calcemic” actions of vitamin D, which are associated with the maintenance of glucose homeostasis, cardiovascular morbidity, autoimmunity, inflammation, and cancer. In parallel, growing evidence has recognized that a multimodal association links vitamin D system to brain development, functions and diseases. With vitamin D deficiency reaching epidemic proportions worldwide, there is now concern that optimal levels of vitamin D in the bloodstream are also necessary to preserve the neurological development and protect the adult brain. The aim of this review is to highlight the relationship between vitamin D and neurological diseases.